The cost of delaying treatment in multiple sclerosis - What is lost is not regained

被引：35
|
作者：
Schwid, SR
Bever, CT
机构：
[1] Univ Rochester, Sch Med & Dent, Dept Neurol, Rochester, NY 14642 USA
[2] VAMHCS Baltimore, Neurol Serv, Baltimore, MD USA
[3] VAMHCS Baltimore, Res Serv, Baltimore, MD USA
[4] Univ Maryland, Sch Med, Dept Neurol, Baltimore, MD 21201 USA
[5] Univ Maryland, Sch Med, Dept Pharmacol & Expt Therapeut, Baltimore, MD 21201 USA
来源：
NEUROLOGY | 2001年 / 56卷 / 12期
关键词：
D O I：
10.1212/WNL.56.12.1620
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：1620 / 1620
页数：1
相关论文
共 50 条
  • [41] Cost of multiple sclerosis in France
    Fromont, A.
    Lehanneur, M.
    Rollot, F.
    Weill, A.
    Clerc, L.
    Kopp, C. Bonithon
    Binquet, C.
    Moreau, T.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 127 - 128
  • [42] Cost of multiple sclerosis in Europe
    Kobelt, G
    Pugliatti, M
    EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 : 63 - 67
  • [43] The cost of multiple sclerosis in Australia
    Taylor, B
    McDonald, E
    Fantino, B
    Sedal, L
    MacDonnell, R
    Pittas, F
    Groom, T
    Beresniak, A
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 238 : S252 - S252
  • [44] Burden and cost of multiple sclerosis
    Kobelt, G.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 111 - 111
  • [45] Multiple sclerosis: cost of the disease
    Tissot, E
    Woronoff-Lemsi, MC
    REVUE NEUROLOGIQUE, 2001, 157 (8-9) : 1169 - 1174
  • [46] Cost of multiple sclerosis in Australia
    Taylor, B
    McDonald, E
    Pittas, F
    Groom, T
    Fantino, B
    Sedal, L
    MacDonnell, R
    Beresniak, A
    MULTIPLE SCLEROSIS, 2004, 10 (7032): : S135 - S135
  • [47] Highly Effective Therapy Versus Escalation Approaches in Early Multiple Sclerosis What Is the Future of Multiple Sclerosis Treatment?
    Rjeily, Nicole Bou
    Mowry, Ellen M.
    Ontaneda, Daniel
    Carlson, Alise K.
    NEUROLOGIC CLINICS, 2024, 42 (01) : 185 - 201
  • [48] COST-EFFECTIVENESS OF OFATUMUMAB IN TREATMENT OF RELAPSING MULTIPLE SCLEROSIS IN TURKEY
    Tatar, M.
    Yarci, B.
    Akdemir, A. C.
    Olmez, C.
    Tinaz, E.
    Turanli, M.
    VALUE IN HEALTH, 2023, 26 (12) : S148 - S148
  • [49] COST-EFFECTIVENESS ANALYSIS OF FAMPRIDINE FOR MULTIPLE SCLEROSIS TREATMENT IN CHINA
    Zhao, X.
    Yang, H.
    Zhao, J.
    Wei, T.
    Liu, J.
    VALUE IN HEALTH, 2022, 25 (07) : S413 - S413
  • [50] WHAT IS MULTIPLE-SCLEROSIS
    不详
    DRUG THERAPY HOSPITAL EDITION, 1977, 2 (06): : 11 - 12
12345